Biology Reference
In-Depth Information
Palermo C, Joyce JA (2008) Cysteine cathepsin proteases as pharmacological targets in cancer.
Trends Pharmacol Sci 29:22-28
Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Harkonen P, Vaananen HK (2001) Estrogen
reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity
of mature osteoclasts. Endocrinology 142:5371-5378
Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ (1997) Matrix metalloproteinases. Br J
Surg 84:160-166
Perdereau C, Godat E, Maurel MC, Hazouard E, Diot E, Lalmanach G (2006) Cysteine cathepsins
in human silicotic bronchoalveolar lavage fluids. Biochim Biophys Acta 1762:351-356
Pham CT, Ley TJ (1999) Dipeptidyl peptidase I is required for the processing and activation of
granzymes A and B in vivo. Proc Natl Acad Sci USA 96:8627-8632
Platt MO, Ankeny RF, Shi GP, Weiss D, Vega JD, Taylor WR, Jo H (2007) Expression
of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased
in endothelium in human atherosclerosis. Am J Physiol Heart Circ Physiol 292:
H1479-H1486
Podgorski I (2009) Future of anticathepsin K drugs: dual therapy for skeletal disease and
atherosclerosis? Future Med Chem 1:21-34
Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, Olive MB, Sloane BF (2009)
Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol
175:1255-1269
Polgar L, Halasz P (1982) Current problems in mechanistic studies of serine and cysteine
proteinases. Biochem J 207:1-10
Premzl A, Zavasnik-Bergant V, Turk V, Kos J (2003) Intracellular and extracellular cathepsin B
facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.
Exp Cell Res 283:206-214
Pungercar JR, Caglic D, Sajid M, Dolinar M, Vasiljeva O, Pozgan U, Turk D, Bogyo M, Turk V,
Turk B (2009) Autocatalytic processing of procathepsin B is triggered by proenzyme activity.
FEBS J 276:660-668
Quintanilla-Dieck MJ, Codriansky K, Keady M, Bhawan J, Runger TM (2008) Cathepsin K in
melanoma invasion. J Invest Dermatol 128:2281-2288
Reddy VY, Zhang QY, Weiss SJ (1995) Pericellular mobilization of the tissue-destructive cysteine
proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad
Sci USA 92:3849-3853
Riese RJ, Chapman HA (2000) Cathepsins and compartmentalization in antigen presentation. Curr
Opin Immunol 12:107-113
Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL,
Chapman HA (1998) Cathepsin S activity regulates antigen presentation and immunity. J Clin
Invest 101:2351-2363
Rodan SB, Duong LT (2008) Cathepsin K - A New Molecular Target for Osteoporosis. IBMS
BoneKEy 5:16-24
Roshy S, Sloane BF, Moin K (2003) Pericellular cathepsin B and malignant progression. Cancer
Metastasis Rev 22:271-286
Roughley PJ, Barrett AJ (1977) The degradation of cartilage proteoglycans by tissue proteinases.
Proteoglycan structure susceptibility proteolysis. Biochem J 167:629-637
Rozhin J, Sameni M, Ziegler G, Sloane BF (1994) Pericellular pH affects distribution and
secretion of cathepsin B in malignant cells. Cancer Res 54:6517-6525
Runger TM, Quintanilla-Dieck MJ, Bhawan J (2007) Role of cathepsin K in the turnover of the
dermal extracellular matrix during scar formation. J Invest Dermatol 127:293-297
Sameni M, Dosescu J, Moin K, Sloane BF (2003) Functional imaging of proteolysis: stromal and
inflammatory cells increase tumor proteolysis. Mol Imaging 2:159-175
Samokhin AO, Wong A, Saftig P, Bromme D (2008) Role of cathepsin K in structural changes in
brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice. Athero-
sclerosis 200:58-68
Search WWH ::




Custom Search